NCT06003374 is a clinical trial of Ultrasound in Septic Arthritis, sponsored by Assiut University.

Who is sponsoring NCT06003374?

NCT06003374 is sponsored by Assiut University.

What drugs are being tested in NCT06003374?

Interventions in NCT06003374: Ultrasound.

What condition does NCT06003374 study?

NCT06003374 studies Septic Arthritis.

Is NCT06003374 still recruiting?

NCT06003374 is currently status unknown. Last updated 22 August 2023.

Last reviewed 2023-08-22 · How we verify

NCT06003374

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Extended Hip Ultrasound as Anew Protocol for Septic Hip in Children

Status unknown Last updated 22 August 2023

What this trial tests

trial testing Ultrasound in Septic Arthritis in 46 participants. Status unknown.

Timeline

15 September 2023

Primary endpoint
1 December 2024

30 January 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	46
Start date	15 September 2023
Primary completion	1 December 2024
Estimated completion	30 January 2025

Drugs / interventions tested

Ultrasound

Conditions studied

Septic Arthritis — all drugs for Septic Arthritis →

Sponsor

Assiut University

Who can join

Adults 1 Week to 15, any sex, with Septic Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To establish a new protocol in order to increase ultrasound diagnostic accuracy of pediatrics presented with signs of septic hip .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ultrasound

Trials testing the same drug.

NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
NCT07505433 — Ultrasound Monitoring of Bone Healing in Ilizarov Bone Transport · not yet recruiting
NCT07498517 — Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT · Phase 2 · not yet recruiting
NCT07342790 — Artificial Intelligence Clinical Decision · NA · not yet recruiting
NCT07169890 — Clinical Insights Into Dextrose Phonophoresis on Mild to Moderate Acne Vulgaris · NA · completed

Other recruiting trials for Septic Arthritis

Currently open trials in the same condition.

NCT07388017 — Infrared Thermography for Diagnosis of Musculoskeletal Infections · recruiting
NCT06630988 — Diagnostic and Management of Hand Infection. · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06003374 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 22 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06003374.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing